its first phase of relocation of the College of Medicine and Veterinary Medicine with the move of medical teaching and research to the adjacent Chancellor’s Building. In 2004 Scottish Enterprise, Scotland’s economic development agency, had acquired the surrounding land with a view to establishing one of Europe’s leading locations for life sciences companies. In 2007, following completion of a series of land deals which cleared a 55-acre site for development adjacent to the Royal Infirmary of Edinburgh, launched the creation of Edinburgh BioQuarter. This was followed in 2006 by The Queens Medical Research Institute (QMRI), with the aim of addressing major disease challenges in Cardiovascular Science, Inflammation Research, Regenerative Medicine and Reproductive Health and the Centre for Regenerative Medicine, officially opened by the Princess Royal, dedicated to the study and development of new regenerative treatments for human diseases and stem cell research to find new therapies for conditions including multiple sclerosis and heart and liver disease. The QMRI also houses part of the Edinburgh Imaging Facility. In August 2010, British author J.K Rowling endowed research at BioQuarter with a £10 million gift to create the Anne Rowling Regenerative Neurology Clinic, in memory of her mother who died in 1990 from complications related to multiple sclerosis. The Clinic was officially opened in October 2013. The first commercial facility on BioQuarter, NINE - Life Sciences Innovation Centre, was established in 2012 to house burgeoning spinouts and startup life sciences companies; this was joined in 2016 by commercial modular facilities in the form of BioCube 1 and BioCube 2. Health Innovation District and Planned Developments By 2035, BioQuarter will be a vibrant Health Innovation District - a new mixed use, urban neighbourhood of Edinburgh, supporting a community of more than 20,000 people and centred on world-leading health innovators and businesses. The £1billion (GDV) development will unlock its full potential, accelerate its growth and deliver a global destination for pioneering health innovation focused on life sciences R&D, data-driven innovation (digital health and med tech), medical teaching, healthcare delivery and commercial enterprise. With plans to expand the city’s tram network to BioQuarter by 2030, the development of the Health Innovation District will support an estimated 9,000 new jobs and deliver a net zero location that promotes the wellbeing of its community and its neighbours. The pipeline of academic and clinical developments include the University of Edinburgh Institute for Regeneration and Repair (due to open in